Emerging therapies for the treatment of relapsed or refractory follicular lymphoma

With no treatment standard having been established for relapsed and refractory follicular lymphoma, a number of therapeutic approaches are used in Canada. In patients who relapse early or who eventually become resistant to subsequent treatment, prognosis is poor, and new approaches are needed. A num...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Curr Oncol
Asıl Yazarlar: MacDonald, D., Prica, A., Assouline, S., Christofides, A., Lawrence, T., Sehn, L.H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Multimed Inc. 2016
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5176374/
https://ncbi.nlm.nih.gov/pubmed/28050137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.3405
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller